Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,251.8
11.1 (0.34%)

 

  • STI Straits Times Index
    3,251.8
    11.1 (0.34%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,606.7
    -3.0 (-0.19%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,920.8
    -5.7 (-0.02%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,903.2
    -6.8 (-0.23%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,370.2
    38.3 (0.16%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,137.0
    -11.7 (-0.19%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,126.1
    2.0 (0.09%)
    Index delayed 20 minutes
  • XAO XAO
    6,844.9
    -32.1 (-0.47%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 460.6M
  • Value: 335.0M
  • Rise: 132
  • Fall: 83
  • Unch: 613

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.191-0.008
Tritech0.027+0.007
Golden Agri-Res0.240+0.010
MarcoPolo Marine0.021-0.001
GSS Energy0.104+0.001
Koh Eco0.058+0.001
Alpha Energy0.036-
Ley Choon0.018+0.002
Addvalue Tech0.024+0.001
Jiutian Chemical0.016+0.001

World Indices

World Indices
Name Last Change
Nasdaq 8,464.3 -11.0
HSI 26,822.0 -104.5
HSCEI 10,593.4 -20.3
Jakarta 6,138.0 -10.8
Nikkei 225 23,370.2 +38.4
SSE Comp 2,894.1 -15.8
Shanghai A 3,032.1 -16.6
Shanghai B 258.0 -1.8
PSE Comp 0.0
KOSPI 2,127.5 +3.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ERYTECH PHARMA SPON ADR EACH REPR 1 ORD ERYTECH PHARMA SPON ADR EACH REPR 1 ORD
Updated on 11 Nov 2019 (End of trading day)
Last (USD): 5.160 Change: +0.250 High: 5.160 Remarks: -
Change (%): +5.08 Low: 5.160
Open 5.160 Yesterday's Close 4.91
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 849 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -2.51406 Trailing EPS (USD) e -3.08070 NAV (USD) b 7.4298
PE a - Trailing PE f - Price / NAV b 0.6944
Dividend (USD) d - Cash In Hand (USD) g 5.6792 Issued & Paid-up Shares c 17,937,000
Dividend Yield (%) d - Price / Cash In Hand g 0.909 Treasury Shares h 2,500
Beta - 75 Daysi -0.156 R-Squared - 75 Days(%)i 0.14 Market Cap (M) 92.548
Beta - 500 Daysi -0.030 R-Squared - 500 Days (%)i 0.01 Enterprise Value (M) -2.942
Piotroski F Score 1 Exchange Code ERYP Par Value ( $ ) n.a.
52 Weeks Volatility (%) 48.50 Free Float (%) 96.5
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 30 Apr 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 10 Nov 2017.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ERYTECH PHARMA SPON ADR EACH REPR 1 ORD NASDAQ 92.548 - - 0.6944 -
Industry Biotechnology NASDAQ 2,360.394 138.784 139.887 5.7110 0.738
Local Peer AMGEN INC NASDAQ 131,136.409 15.623 16.256 12.0012 2.535
Local Peer GILEAD SCIENCES INC NASDAQ 81,779.296 14.992 30.367 3.9691 3.574
Local Peer CELGENE CORP NASDAQ 77,982.503 19.274 13.262 6.4518 -
Local Peer BIOGEN INC NASDAQ 53,075.210 11.979 9.837 3.7922 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 51,918.585 24.766 24.218 9.8829 -
Local Peer ILLUMINA INC NASDAQ 43,365.000 52.500 44.568 9.7691 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 37,800.557 15.464 17.629 3.5985 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 24,122.932 310.862 16.407 2.3269 -
Local Peer SEATTLE GENETICS INC NASDAQ 18,561.104 - - 10.4299 -
Local Peer INCYTE CORPORATION NASDAQ 18,278.589 166.939 45.136 7.5453 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 13,531.151 - - 4.4012 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 11,579.102 - - 7.4516 -
Other Local Peers GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), MODERNA INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), 10X GENOMICS INC (NASDAQ), EXELIXIS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), REPLIGEN CORP (NASDAQ), BLUEBIRD BIO INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), IMMUNOMEDICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), NATERA INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), UNIQURE N.V. (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), NEXTCURE INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), INSMED INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), REGENXBIO INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), ALECTOR INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), VERACYTE INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), INTREXON CORP (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), OMEROS CORP (NASDAQ), CORTEXYME INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), RETROPHIN INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), SYNTHORX INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), IMMUNOGEN INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), UROGEN PHARMA LTD (NASDAQ), AGENUS INC (NASDAQ), AVROBIO INC (NASDAQ), CYTOKINETICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), MORPHIC HOLDING INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), XBIOTECH INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), DERMIRA INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), MERUS B V (NASDAQ), ARDELYX INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), MEDICINOVA INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), COMPUGEN (NASDAQ), PDL BIOPHARMA INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), PERSONALIS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), RESTORBIO INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), GERON CORP (NASDAQ), AVID BIOSERVICES INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), MANNKIND CORPORATION (NASDAQ), SERES THERAPEUTICS (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), CHIASMA INC (NASDAQ), KAMADA (NASDAQ), XOMA CORP (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), CUE BIOPHARMA INC (NASDAQ), ATHERSYS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), BICYCLE THERAPEUTICS LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), IVERIC BIO INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), IMV INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), SESEN BIO INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), NANTKWEST INC (NASDAQ), NOVAVAX INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), CHIMERIX INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), ADURO BIOTECH INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), VERASTEM INC (NASDAQ), VACCINEX INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), ARAVIVE INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), SYNLOGIC INC (NASDAQ), INFLARX N V (NASDAQ), TREVENA INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), VERMILLION INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), ORGENESIS INC (NASDAQ), EQUILLIUM INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), CURIS INC (NASDAQ), INMUNE BIO INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), EVOGENE LTD (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), SAVARA INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), BIOCARDIA INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), ZAFGEN INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), CONTRAFECT CORP (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), SOLIGENIX INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), SENESTECH INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), BIONANO GENOMICS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), BIOCEPT INC (NASDAQ), TOCAGEN INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), PRECIPIO INC (NASDAQ), ATYR PHARMA INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), TROVAGENE INC (NASDAQ), VAXART INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), OCUGEN INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 20 ORD SHS (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ADVAXIS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SPHERIX INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), OPGEN INC (NASDAQ)
Global Peer CSL ASX 122,798.526 45.770 45.770 16.4100 0.981
Global Peer AMGEN-T HKEx 594,184.000 9.032 9.399 6.9364 4.385
Global Peer AGILENT TECHNOLOGIES INC NYSE 23,782.616 75.261 22.185 5.0100 0.797
Global Peer SINO BIOPHARM HKEx 139,085.908 12.980 13.397 4.0861 0.662
Global Peer WUXI BIO HKEx 105,310.554 140.996 110.226 10.8404 -
Global Peer BEIGENE HKEx 89,820.817 - - 7.3990 -
Global Peer GENSCRIPT BIO HKEx 34,623.644 208.226 - 9.7640 -
Global Peer 3SBIO HKEx 33,730.802 22.298 27.140 3.3246 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 2,773.500 44.234 645.000 2.6797 -
Global Peer HAOHAI BIOTEC HKEx 13,313.685 27.115 30.051 3.1346 0.781
Other Global Peers FRONTAGE (HKEx), CKLIFE SCIENCES (HKEx), POLYNOVO LIMITED (ASX), VIVA BIOTECH (HKEx), ASCENTAGE-B (HKEx), AVITA MEDICAL LTD (ASX), MESOBLAST LTD (ASX), ASCLETIS-B (HKEx), MYOVANT SCIENCES LTD (NYSE), ESSEX BIO-TECH (HKEx), KADMON HLDGS INC (NYSE), ARCUS BIOSCIENCES INC (NYSE), LEE'S PHARM (HKEx), STARPHARMA HOLDINGS LIMITED (ASX), TELIX PHARMACEUTIC (ASX), NEXT SCIENCE LTD (ASX), PFENEX INC (NYSE American), DPHARMA (Bursa), NEUREN PHARMACEUTICALS LTD (ASX), 22ND CENTURY GROUP INC (NYSE American), BBI LIFE SCI (HKEx), ENZO BIOCHEM INC (NYSE), RESAPP HEALTH LIMITED (ASX), UNI-BIO GROUP (HKEx), NANOVIRICIDES INC (NYSE American), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), PHYLOGICA LIMITED (ASX), CYNATA THERAPEUTICS LTD (ASX), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ONCOSIL MEDICAL LIMITED (ASX), CEL-SCI CORP (NYSE American), IMUGENE LIMITED (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), ORTHOCELL LIMITED (ASX), CT ENTERPRISE (HKEx), PORT (SET), ARMATA PHARMACEUTICALS INC (NYSE American), BIONOMICS LTD (ASX), NOVITA HEALTHCARE LTD (ASX), REGENT PACIFIC (HKEx), ACTINOGEN MEDICAL LTD (ASX), BIOTRON (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), MEMPHASYS LTD (ASX), RHINOMED LIMITED (ASX), BIOSINO BIO-TEC (HKEx), EXTRAWELL PHAR (HKEx), INVEX THERAPEUTICS LTD NPV (ASX), ORAGENICS INC (NYSE American), ACTINIUM PHARMACEUTICALS INC (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), ISORAY INC (NYSE American), IMMURON LIMITED (ASX), PROTEOMICS INTL LABORATORIES LTD (ASX), REGENEUS LTD (ASX), PATRYS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), IBIO INC (NYSE American), ADALTA LTD (ASX), ANTEO DIAGNOSTICS LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), CELLMID LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), CCP TECHNOLOGIES LTD (ASX), GENETIC TECHNOLOGIES (ASX), BENITEC BIOPHARMA LTD (ASX), MEGASUN (Bursa), NOVABAY PHARMACEUTICALS INC (NYSE American), HAO WEN HLDGS (HKEx), AUSTRALIAN PRIMARY HEMP LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), BIOXYNE LIMITED (ASX), MGRC (Bursa), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), IMMUTEP LTD (ASX), MEDIBIO LIMITED (ASX), TBG DIAGNOSTICS LTD (ASX), AIM IMMUNOTECH INC (NYSE American), AVECHO BIOTECHNOLOGY LTD (ASX), NANOLLOSE LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), BPH ENERGY LIMITED (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.360
+7.49 %
10 Days -+0.870
+20.27 %
20 Days -+1.140
+28.35 %
Medium Term Return 3 Months --0.554
-9.70 %
6 Months --2.220
-30.09 %
1 Year --2.720
-34.52 %
Long Term Return 2 Years --21.470
-80.62 %
Annualised Return Annualised --
-55.98 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 3.946 - 10.650 Change From 1 Year Low +1.214 % Change From 1 Year Low (%) +30.76
Change From 1 Year High -5.490 % Change From 1 Year High (%) -51.55
2 Years Range 3.946 - 30.560 Change From 2 Years Low +1.214 % Change From 2 Years Low (%) +30.76
Change From 2 Years High -25.400 % Change From 2 Years High (%) -83.12
5 Years Range 3.946 - 30.560 Change From 5 Years Low +1.214 % Change From 5 Years Low (%) +30.76
Change From 5 Years High -25.400 % Change From 5 Years High (%) -83.12
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. It engages in developing and producing therapeutic products for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France.

Historical Price Data

Date Open High Low Close Volume VWAP
08 Nov 2019 4.910 4.910 4.910 4.910 - -
07 Nov 2019 4.910 4.910 4.910 4.910 - -
06 Nov 2019 4.800 5.125 4.800 4.910 3,599 -
05 Nov 2019 4.800 4.800 4.800 4.800 110 -
04 Nov 2019 4.580 4.580 4.580 4.580 824 -
01 Nov 2019 4.320 4.320 4.320 4.320 - -
31 Oct 2019 4.400 4.490 4.320 4.320 724 -
30 Oct 2019 4.290 4.290 4.290 4.290 - -
29 Oct 2019 4.290 4.290 4.290 4.290 - -
28 Oct 2019 4.290 4.290 4.290 4.290 - -
25 Oct 2019 4.290 4.290 4.290 4.290 - -
24 Oct 2019 4.290 4.290 4.290 4.290 - -
23 Oct 2019 4.290 4.290 4.290 4.290 - -
22 Oct 2019 4.290 4.290 4.290 4.290 - -
21 Oct 2019 4.130 4.290 4.016 4.290 5,100 -
18 Oct 2019 4.135 4.135 4.135 4.135 - -
17 Oct 2019 4.135 4.135 4.135 4.135 - -
16 Oct 2019 4.050 4.160 4.050 4.135 6,622 -
15 Oct 2019 4.020 4.020 4.020 4.020 - -
14 Oct 2019 4.020 4.020 4.020 4.020 - -
11 Oct 2019 4.020 4.020 4.020 4.020 - -
10 Oct 2019 4.020 4.020 4.020 4.020 - -
Summary
Current 2 Weeks
(28 Oct 2019 to 08 Nov 2019)
4.290 5.125 4.290 4.910 5,257 -
Previous 2 Weeks
(14 Oct 2019 to 25 Oct 2019)
4.020 5.125 4.020 4.290 11,722 -
4 Weeks from
(16 Sep 2019 to 11 Oct 2019)
5.210 5.210 4.290 4.020 12,583 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.